Historical shareholding details of Public holdings in Ajanta Pharma Ltd. (AJANTPHARM)

Quarterly changes of Public shareholding in Ajanta Pharma Ltd. over the previous quarters

Quarter Name Total no. shares held Percent Holding Pledged Locked
shares % shares %
Mar 2025 Total 9,228,924 7.38% 0 0.00% 25,325 7.99%
Dec 2024 Total 9,309,881 7.45% 0 0.00% 25,325 8.07%
Sep 2024 Total 9,391,309 7.51% 0 0.00% 25,325 8.07%
Jun 2024 Total 9,917,792 7.94% 0 0.00% 1,000 0.01%
Mar 2024 Total 9,768,784 7.76% 0 0.00% 1,000 0.01%
Dec 2023 Total 10,080,503 8.00% 0 0.00% 1,000 0.01%
Sep 2023 Total 10,328,003 8.21% 0 0.00% 1,000 0.01%
Jun 2023 Total 9,801,518 7.78% 0 0.00% 1,000 0.01%
Apr 19, 2023 Total 9,740,912 7.74% 0 0.00% 1,500 0.02%
Mar 2023 Total 10,133,167 7.91% 0 0.00% 1,500 0.02%
Dec 2022 Total 10,244,507 8.00% 0 0.00% 1,500 0.02%
Sep 2022 Total 10,443,842 8.15% 0 0.00% 1,500 0.02%
Jun 2022 Total 10,645,636 8.32% 0 0.00% 7,500 0.57%
Mar 2022 Total 6,951,768 8.14% 0 0.00% 4,000 0.58%
Dec 2021 Total 7,026,427 8.12% 0 0.00% 4,000 0.56%
Sep 2021 Total 7,298,132 8.43% 0 0.00% 9,500 1.12%
Jun 2021 Total 7,329,343 8.48% 0 0.00% 5,500 0.57%
Mar 2021 Total 7,504,574 8.67% 0 0.00% 5,500 0.58%
Dec 2020 Total 8,025,269 9.27% 0 0.00% 5,500 0.54%
Sep 2020 Total 8,367,933 9.59% 0 0.00% 0 0.00%
Jun 2020 Total 8,281,939 9.49% 0 0.00% 6,500 0.69%
Mar 2020 Total 8,037,723 9.22% 0 0.00% 7,500 0.66%
Dec 2019 Total 8,119,383 9.31% 0 0.00% 7,500 0.84%
Sep 2019 Total 8,157,703 9.36% 0 0.00% 7,500 0.81%
Jun 2019 Total 8,377,412 9.60% 0 0.00% 8,500 0.68%
Mar 2019 Total 8,497,541 9.74% 0 0.00% 8,500 0.63%
Dec 2018 Total 8,628,902 9.80% 0 0.00% 8,500 0.66%
Sep 2018 Total 8,990,840 10.21% 0 0.00% 8,500 0.61%
Jun 2018 Total 9,417,714 10.69% 0 0.00% 9,500 0.33%
Mar 2018 Total 9,082,308 10.32% 0 0.00% 0 0.00%
Dec 2017 Total 9,384,509 10.65% 0 0.00% 9,500 0.36%
Sep 2017 Total 10,267,901 11.67% 0 0.00% 9,500 0.30%
Jun 2017 Total 10,921,332 12.41% 0 0.00% 1,000 0.01%
Mar 2017 Total 11,574,268 13.15% 0 0.00% 3,750 0.27%

View all shareholdings details of Ajanta Pharma Ltd.